Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2003
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186921 Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
10/02/2003US20030186918 Increasing growth factor production by cells
10/02/2003US20030186916 Vector for transfection of eukaryotic cells
10/02/2003US20030186913 Introducing preparation comprising a pharmaceutically acceptable injectable carrier and naked polynucleotide operatively coding for the polypeptide into interstitial space of the heart
10/02/2003US20030186912 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
10/02/2003US20030186910 Anticarcinogenic agents
10/02/2003US20030186908 Microorganisms transformed with Ig-Like polypeptide and uses thereof
10/02/2003US20030186907 Endometrial function
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186904 Keratinocyte growth factor-2
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186436 Insulin-secreting cell which codes and expresses glucagon-like peptides-1 (GLP-1) for treating diabetes and autoimmune diseases
10/02/2003US20030186433 Novel fibroblast growth factor and nucleic acids encoding same
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186415 Mutant possessing uracil phosphoribosyl transferase activity
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186383 Comprise nucleotide sequences coding growth factor polypeptide for diagnosing and treating autoimmune, cell proliferative, atherosclerotic, inflammatory and cancer disorders; tissue engineering; wound healing agents
10/02/2003US20030186360 Comprises nucleotide sequences coding membrane protein for use in diagnosis and treatment of disorders of colon, urogenital and autoimmune systems
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186286 Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
10/02/2003US20030186271 Pharmaceutical compositions in particulate form
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186253 Fibroblast growth factor-13
10/02/2003US20030186244 Using stored nucleotide sequence information to screen genome databases to detect restriction fragment length polymorphisms which are associated with genetic disorders
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185879 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
10/02/2003US20030185855 Which has lost its transducing properties as a result of a DNA sequence change in the gene coding for Vmw65 protein; expressable heterologous gene inserted; under the control of the immediate early 1 gene enhancer of cytomegalovirus
10/02/2003US20030185843 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185820 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185810 Tumor radiosensitization using gene therapy
10/02/2003US20030185809 First population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene
10/02/2003US20030185806 Intact cells that express major histocompatibility antigens with a number of common allotypes from a given mammalian species.
10/02/2003US20030185802 DNA construct operably encoding a vascular endothelial growth factor receptor protein.
10/02/2003US20030185801 Packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35.
10/02/2003US20030185794 Such as a pleiotrophin or midkine molecule in a pharmaceutically acceptable carrier.
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479724A1 Gene amplification in cancer
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479530A1 Hiv therapeutic
10/02/2003CA2479167A1 Raav vector compositions and methods for the treatment of choroidal neovascularization
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/01/2003EP1348768A2 Method of treatment, diagnosis or detection of diabetes
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348033A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1094843B1 Targeted site specific drug delivery compositions and uses
10/01/2003EP1056467B1 Method for the treatment of diseases or disorders of the inner ear
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446105A Medicinal compositions for angiogenic therapy
10/01/2003CN1445366A New protein kinase specific to human cardiac muscle and its coded sequence
10/01/2003CN1122716C Extracorporeal ceel culture and transplantation kits
09/2003
09/30/2003US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it
09/30/2003US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance
09/30/2003US6627619 Cancer diagnosis
09/30/2003US6627616 Intravascular delivery of non-viral nucleic acid
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627442 Methods for stable transduction of cells with hiv-derived viral vectors
09/30/2003US6627422 Non-degradable monofilaments; cylinders; use for implantations and treatment of diabetes, haemophilia, anemia, thalassemia, Parkinson's disease and amyotropic lateral sclerosis
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627403 Detecting hyperplasia in tissue sample; obtain tissue sample, isolate nucleotide sequence, detect chymotryptic nucleotide sequences, presence of sequences indicates hyperplasia
09/30/2003US6627215 Devices for improved wound management
09/30/2003US6627204 Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627190 Telomerase resistance; anticancer agents
09/30/2003US6627189 Supressing expression of human p21 K-ras oncogene
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/25/2003WO2003079020A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
09/25/2003WO2003078660A2 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith
09/25/2003WO2003078658A2 Methods for diagnosing and treating schizophrenia
09/25/2003WO2003078623A1 Functional molecule and process for producing the same
09/25/2003WO2003078619A1 Hybrid and single chain meganucleases and use thereof
09/25/2003WO2003078597A2 Tissue engineering
09/25/2003WO2003078595A2 Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response
09/25/2003WO2003078592A2 Method for the purification, production and formulation of oncolytic adenoviruses
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 870